a-Acetyl digoxin

CAS: 5511-98-8

Ref. 3D-OA16441

Informação sobre produto

• Nome: a-Acetyl digoxin
• Sinónimos: (3b,5b,12b)-3-[(O-3-O-Acetyl-2,6-dideoxy-b-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-b-D-ribo- hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide, (3β,5β,12β)-3-[(O-3-O-Acetyl-2,6-dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide, 3'''-Acetyldigoxin, 3-{[3-O-acetyl-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->6)-2,4-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide, Acetyl-digoxin-alpha, Card-20(22)-enolide, 3-((O-3-O-acetyl-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.4)-O-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-, Card-20(22)-enolide, 3-[(O-3-O-acetyl-2,6-dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-, Desglucolanatoside C, Digorid A, Digoxigenin + zuckerkette wie bie acetyl-digitoxin A, Digoxigenin + zuckerkette wie bie acetyl-digitoxin A [German], Digoxin, 3'''-acetate, Digoxin, acetate, alpha-, Digoxin, acetyl-, Digoxin, α-acetate, Digoxin, α-acetyl-, Lanadigin, Lanatilin, Sandolanid, alpha-Acetyldigoxin, α-Acetyldigoxin, (3β,5β,12β)-3-[(O-3-O-Acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide, Card-20(22)-enolide, 3-[(O-3-O-acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-

Descrição

Digoxin is a pharmaceutical drug that is used to manage congestive heart failure and ventricular arrhythmias. It binds to the peptide receptors in the cardiac muscle cells, which leads to an increase in the force of contraction and a decrease in the rate of cell depolarization. Digoxin may also be effective in treating inflammatory lesions and other conditions caused by enzyme inhibitors. The binding affinity of digoxin for these receptors is increased when it is acetylated at its beta-position. This change can be detected by uv absorption and can be quantified using high-performance liquid chromatography (HPLC). A purified preparation of acetyl digoxin has been shown to have biochemical properties similar to those of natural digoxin.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 822.98 g/mol
• Fórmula: C₄₃H₆₆O₁₅
• Pureza: Min. 95%